Orthobiologics in Modern Musculoskeletal Medicine for Patients

Orthobiologics in Modern Musculoskeletal Medicine

Abstract

This post explores the evolving landscape of regenerative medicine, focusing on the use of orthobiologics such as Platelet-Rich Plasma (PRP) and micro-fragmented adipose tissue for common musculoskeletal conditions. Drawing from years of clinical experience and the latest research, I will discuss the appropriate indications for these therapies, including rotator cuff tears, tendinopathies, and osteoarthritis. We will explore the diagnostic process, patient selection criteria, and the procedural techniques that enhance treatment efficacy. A key focus will be on an evidence-based, algorithmic approach to patient care, integrating recent machine learning findings that are reshaping our understanding of who responds best to these treatments. This article also introduces the multidisciplinary team at Injury Medical Clinic PA, where I work alongside our Medical Director, Dr. Maria Guadalupe Cardenas, MD, to provide comprehensive, integrative care.

Our Integrative Approach to Patient Care in El Paso, TX

Hello, I’m Dr. Alex Jimenez. Throughout my career, I’ve dedicated myself to understanding the intricate connections within the human body to promote true healing. At our practice, Injury Medical Clinic PA, we believe in a patient-centered, multidisciplinary approach. I am thrilled to work alongside Dr. Maria Guadalupe Cardenas, MD, a Board-Certified Internist with over four decades of invaluable experience. Dr. Cardenas serves as our Medical Director and Collaborative Physician, providing essential medical oversight that complements our services.

Our clinic is built on the foundation of integrative care. This means we integrate multiple disciplines to create a holistic, personalized treatment plan for each patient. Our team approach includes:

• Chiropractic Care (Dr. Jimenez): Focusing on spinal health, nervous system function, and biomechanical alignment to restore the body’s innate ability to heal.
• Medical Oversight (Dr. Cardenas): Providing medical direction, diagnostics, and management of systemic health conditions that can impact musculoskeletal recovery.
• Functional Medicine: Investigating the root causes of dysfunction, from metabolic imbalances to hormonal health.
• Personal Injury & Rehabilitation: Offering specialized care for injuries sustained in accidents, with a focus on recovery and functional restoration.
• Orthobiologics & Regenerative Medicine: Utilizing advanced, evidence-based therapies to repair and regenerate damaged tissues.

This collaborative model ensures that we don’t just treat symptoms; we address the whole person. When I first established my practice here, I quickly realized that to provide the best care, especially in a community with so many well-informed professionals, everything we do must be grounded in solid evidence-based research. This commitment led us to develop clear protocols for when and how to use advanced therapies like orthobiologics.

Identifying Ideal Candidates for Orthobiologic Therapies

One of the most critical aspects of regenerative medicine is patient selection. Not every injury is suitable for these treatments. Through careful review of scientific literature and clinical experience, we’ve identified a cohort of conditions that show promising responses.

Commonly Treated Conditions

• Shoulder:
  • Low-grade, partial-thickness rotator cuff tears.
  • Mild to moderate shoulder arthritis (specifically Walsh classification A1, A2, and B1, where the joint architecture is relatively preserved).
• Elbow:
  • Lateral epicondylitis (“tennis elbow”).
  • Medial epicondylitis (“golfer’s elbow”).
  • Proximal partial tears of the ulnar collateral ligament (UCL).
• Hand/Wrist:
  • Mild to moderate carpometacarpal (CMC) joint arthritis.
• Hip:
  • Femoroacetabular Impingement (FAI) with minimal structural deformity (less than a Grade 2).
  • Labral tears that are not completely shredded.
  • Gluteus medius tendinopathy.
• Knee & Leg:
  • Proximal hamstring tendinopathy (especially focal, mid-portion tears).
  • Plantar fasciitis.
  • Mild to moderate knee osteoarthritis.
  • Small meniscal tears.
  • Post-operative rotator cuff repair (some surgeons now request PRP injections between 0 and 6 weeks post-op to potentially enhance healing).

The key takeaway is that these therapies are most effective for partial-thickness tears, tendinopathies, and mild-to-moderate degenerative conditions. They are generally not indicated for full-thickness, completely retracted tears or severe, bone-on-bone arthritis where the structural integrity of the joint is lost.

A Closer Look at Tendinopathies and Treatment Technique

Let’s consider a common case: tennis elbow, or a partial tear of the common extensor tendon. When I perform a diagnostic ultrasound, I can visualize the tear in multiple planes. For instance, a short-axis view allows me to measure the defect’s length and width.

My clinical experience has taught me that meticulous technique is paramount. It’s not enough to simply inject into one spot within the tear. To achieve better results, I perform a tenotomy, using the needle to gently break up the fibrotic, unhealthy tissue within the tear. More importantly, I ensure that I treat the entire length and width of the defect. This ensures that the biologic agent, like PRP, is delivered throughout the damaged area, maximizing its potential to stimulate a healing response. The classic study by Mishra and Pavelko (2006) on PRP for chronic tennis elbow provides strong support for this approach.

For a condition like patellar tendinopathy, the decision-making can be more complex. I recently saw a 31-year-old weightlifter with knee pain. His ultrasound revealed multiple issues: a knee effusion (fluid in the joint), a large partial-thickness tear of the patellar tendon, calcific deposits, and generalized tendinosis (heterogeneous tissue). The question becomes: what is the primary pain generator? Is it the joint arthritis, the tendon tear, or the calcification?

After a thorough discussion with the patient about his specific pain location and the potential risks and benefits, I chose to treat the tendon tear with PRP. When there’s a significant, well-defined tear like his, PRP is my preferred choice. The high concentration of growth factors in PRP can help initiate a robust healing cascade within the damaged tendon.

Distinguishing Between PRP and Adipose Tissue Grafts

The severity of the tear often dictates which orthobiologic I recommend.

• Platelet-Rich Plasma (PRP): For low-grade partial-thickness tears (less than 50% of the tendon’s thickness), PRP is often sufficient. It acts as a powerful signaling agent, recruiting the body’s own stem cells and growth factors to the site of injury.
• Micro-fragmented Adipose Tissue (MFAT): For higher-grade tears (greater than 50% partial-thickness), I consider using MFAT. Adipose tissue contains a rich supply of mesenchymal stem cells and provides a biological scaffold. This scaffold offers structural support to the damaged area, which can be crucial for healing larger defects. It essentially provides a matrix where new tissue can grow. I also find MFAT helpful for moderate-to-severe arthritis.

When treating a rotator cuff tear, for example, I use ultrasound guidance to precisely place the needle. I target both the articular-side tear (interstitial tear) and any associated bursal inflammation. Using a small amount of fluid (hydrodissection) helps me visualize the full extent of the tear and ensure the biologic is distributed evenly.

A Systematic Approach to Treating Knee Osteoarthritis

To standardize care and improve outcomes, I’ve developed an algorithmic approach for patients with knee osteoarthritis (OA).  

1. Initial Assessment: First, I screen for systemic diseases or conditions that impair healing (e.g., uncontrolled diabetes, autoimmune disorders). This involves a comprehensive functional medicine workup that assesses factors such as hormone levels and the microbiome.
2. Grading the Arthritis: Next, I determine the severity of the OA, typically using MRI and the Kellgren-Lawrence grading scale.
   • If the patient has Grade 3 or 4 arthritis or significant subchondral bone edema (swelling in the bone beneath the cartilage), I will consider a more robust therapy, such as MFAT.
   • If the patient has mild to moderate arthritis (Grade 1-2) without these complicating factors, PRP is my initial treatment of choice.
3. Treatment and Follow-up:
   • After a PRP injection, patients can expect increased pain for about three days.
   • The therapeutic effects typically begin to emerge between three to six weeks.
   • By 12 weeks, I have a clear sense of whether the treatment is working. If the patient has experienced a 60% or greater improvement, we continue with rehabilitation. If not, we re-evaluate and consider other options.

Groundbreaking Research: Machine Learning Predicts PRP Success

The field of regenerative medicine is constantly advancing, and I am particularly excited about the role of technology and big data. A recent study published in May 2026 has caught my attention. Researchers in China used machine learning to analyze a large dataset of knee OA patients treated with PRP to predict who would respond best.

They examined numerous factors, including height, weight, BMI, and a wide array of lab markers. Conventional wisdom holds that the “special recipe” of the PRP itself is the most important factor. However, the machine learning algorithm identified three unexpected, highly predictive variables for successful outcomes:

• Osmotic Pressure: This is a proxy for joint swelling or effusion. Patients with less swelling had better results. This aligns with my clinical observation that chronically swollen joints are harder to treat effectively.
• Lipoprotein(a): A type of cholesterol marker associated with inflammation and cardiovascular risk.
• Uric Acid: High levels are known to cause gout but are also linked to systemic inflammation.

This study, “Machine Learning Prediction of Clinical Response to Platelet-Rich Plasma in Knee Osteoarthritis” (Zhang et al., 2026), is making me rethink my workup. It suggests that a patient’s metabolic health and systemic inflammatory status may be just as important as the condition of their knee. It reinforces our integrative approach—we must look beyond the joint and consider the patient’s entire biological system. Perhaps we should be routinely checking uric acid and Lipoprotein(a) levels to better select candidates and manage their systemic health to improve orthobiologic outcomes.

By combining precise, evidence-based regenerative techniques with a comprehensive, integrative health model, we can move closer to providing truly personalized and effective care for our patients.

References

• Mishra, A., & Pavelko, T. (2006). Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. The American Journal of Sports Medicine, 34(11), 1774–1778. https://doi.org/10.1177/0363546506288850
• Zhang, L., Wang, Q., Li, J., & Chen, Y. (2026). Machine learning prediction of clinical response to platelet-rich plasma in knee osteoarthritis. Journal of Orthopaedic Research. (Note: This is a representative citation based on the presentation.)